Ljubljana, Slovenia 2006/Results & Conclusions
From 2006.igem.org
Home | Background and Signalling Pathway | Project & Model | Methods | Terms & References | Team members |
---|
Results
Construction of Biobricks
We prepared individual BioBricks that could be used in mammalian cells. The following BioBricks were used:
- promoter (constitutive CMV and NF-κB inducible promoter),
- terminator (which we included into plasmids to avoid repeated additional steps in construction of each functional Part
- protein coding sequences, which include:
- two inhibitory (dominant negative) proteins of the signaling cascade (dnMyD88 and dnTRAF6),
- two reporters: Renilla luciferase (in order to allow simultaneous dual luciferase assay to normalize the luminescence for the efficiency of transfection and cell number) and GFP
- PEST sequence to decrease the lifetime of the inhibitor.
Linkers between the protein coding sequences (e.g. MyD88+luciferase+PEST) were prepared by PCR ligation to avoid addition of unwanted aminoacids in the linker region between the protein domains.
Registration number | Part's Name | Part/Device | Vector |
---|---|---|---|
[http://partsregistry.org/Part:BBa_J52008 BBa_J52008] | rluc | Part | pSB1AK3 |
[http://partsregistry.org/Part:BBa_J52010 BBa_J52010] | NFκB | Part | pSB1AK3 |
[http://partsregistry.org/Part:BBa_J52011 BBa_J52011] | dnMyD88-likn-rLuc | Part | pSB1AK3 |
[http://partsregistry.org/Part:BBa_J52012 BBa_J52012] | rluc-link-PEST191 | Part | pSB1AK3 |
[http://partsregistry.org/Part:BBa_J52013 BBa_J52013] | dnMyD88-link-rluc-link-pest191 | Part | pSB1AK3 |
[http://partsregistry.org/Part:BBa_J52014 BBa_J52014] | NFκB+dnMyD88-link-rLuc | Device | pSB1AK3+TER |
[http://partsregistry.org/Part:BBa_J52016 BBa_J52016] | eukaryotic terminator | Part | pSB1AK3+TER |
[http://partsregistry.org/Part:BBa_J52017 BBa_J52017] | eukaryotic terminator vector | pSB1AK3 | |
[http://partsregistry.org/Part:BBa_J52018 BBa_J52018] | NFκB+rLuc | Device | pSB1AC3 |
[http://partsregistry.org/Part:BBa_J52019 BBa_J52019] | dnTRAF6 | Part | pSB1AK3+TER |
[http://partsregistry.org/Part:BBa_J52021 BBa_J52021] | dnTRAF6-link-GFP | Part | pSB1AK3+TER |
[http://partsregistry.org/Part:BBa_J52022 BBa_J52022] | NFκB+dnTRAF6-link-GFP | Device | pSB1AK3 |
[http://partsregistry.org/Part:BBa_J52023 BBa_J52023] | NFκB+rLuc-link-PEST191 | Device | pSB1AK3 |
[http://partsregistry.org/Part:BBa_J52024 BBa_J52024] | NFκB+dnMyD88-link-rLuc-link-PEST191 | Device | pSB1AK3+TER |
[http://partsregistry.org/Part:BBa_J52026 BBa_J52026] | dnMyD88-link-GFP | Part | pSB1AK3+TER |
[http://partsregistry.org/Part:BBa_J52027 BBa_J52027] | NFκB+dnMyD88-link-GFP | Device | pSB1AK3 |
[http://partsregistry.org/Part:BBa_J52028 BBa_J52028] | GFP-PEST191 | Part | pSB1AK3 |
[http://partsregistry.org/Part:BBa_J52029 BBa_J52029] | NFκB+GFP-PEST191 | Device | pSB1AK3 |
[http://partsregistry.org/Part:BBa_J52034 BBa_J52034] | CMV | Part | pSB1AK3+TER |
[http://partsregistry.org/Part:BBa_J52035 BBa_J52035] | dnMyD88 | Part | pSB1AK3+TER |
[http://partsregistry.org/Part:BBa_J52036 BBa_J52036] | NFκB+dnMyD88 | Device | pSB1AK3+TER |
[http://partsregistry.org/Part:BBa_J52038 BBa_J52038] | CMV-rLuc | Device | pSB1AK3+TER |
[http://partsregistry.org/Part:BBa_J52039 BBa_J52039] | CMV+rLuc-link-PEST191 | Device | pSB1A2 |
[http://partsregistry.org/Part:BBa_J52040 BBa_J52040] | CMV+GFP-PEST191 | Device | pSB1AK3 |
[http://partsregistry.org/Part:BBa_J52642 BBa_J52642] | GFP | Part | pSB1AK3+TER |
[http://partsregistry.org/Part:BBa_J52648 BBa_J52648] | CMV+GFP | Device | pSB1AK3+TER |
Phosphorylation of ERK kinases reflects the activation of the TLR signaling
Our Flow Cytometry experiments showed that 20 minute stimulation of cells transfected with dnMyD88 has little efect, but after 80 minute stimulation the increase in the level of phosphorylated ERK kinases was evident(Picture 22). Untransfected cells gave similar results, as shown on Picture 23. Further optimization of the method would be necessary in order to see a difference between dnMyD88 transfected cells and wild type.
Detection of free NF-kB in whole cell extracts dependent on time after stimulation with LPS with ELISA method
Cells were transfected with TLR4 plasmid and MD2 plasmid, no construct. We have shown that cells with TRL4 receptor respond to LPS stimulation and that ELISA is apropriate and sensitive method for detection of stimulation. However we did not get satisfying results when stimulating (with LPS or flagellin) cells transfected nither with dnMyD88 nor dnTRAF6. We had problems with low rate of transfection and possibly bad primary antibodies.
Inducible transcription by stimulation of Toll-like receptor
Stimulation of HEK293 cells transfected by TLR with their agonist (flagellin in case of TLR5) stimulates the translocation of NF-κB into the nucleus and activation of transcription of NF-κB-responsive genes. We have used the firefly luciferase under the NF-κB dependent promoter to monitor the promotor activation. We tested the functionality of our part containing NF-κB dependent promotor in a construct with dnMyD88-rluc. This promoter is inducible and we detected the R-luciferase activity only in stimulated cells with significant activity appearing a few hours after the cell stimulation.
We also measured F-luciferase activity. We expected a decrease in activity after a certain amount of time. We did not detect it, which could be due to our experiment not lasting long enough or perhaps the fusion of dnMyD88 with the renilla luciferase stericali hindered the activity of dnMyD88. That is why our future experiments were conducted only with dnMyD88.
Inhibition of cell signaling by a feedback device
<p>An adapter protein MyD88, consisting of a TIR and death domain, is at the crossroads of Toll-like receptors. Therefore activation of each of the surface expressed TLR recruits MyD88 to the cell membrane. We selected to use the receptor TLR5 and flagellin instead of the often used TLR4 and its agonist LPS, because the TLR4 system is extremely sensitive to the contamination with bacterial LPS, which often copurifies with the plasmid. In this way we have avoided the contamination issue, but our system is designed to work on any signalling receptor that has MyD88 in its signalling pathway (i.e. TLR1,2,4,5,6,7,8,9,11,IL-1).
Cells were cotransfected with TLR5, reporter plasmid (NFκB-Fluc) and our feedback device (NF-κB-dnMyD88).We expect that after stimulation with flagellin cytoplasmic NF-κB is released from its inhibitor. It then migrates into the nucleus and induces the transcription of our construct. Accumulation of the dominant negative protein should compete with wild-type MyD88 and attenuate the downstream signalling pathway. We can detect the NF-κB translocation, transcriptional activation and phosphorylation by our detection systems - luminescence, free NF-κB, phosphorylation detected by flow cytometry and confocal microscopy. In case that our construct is followed by PEST (degradation) sequence, it is expected that product should degrade rapidly and shorten the inhibition period. If the stimulus is still present, cells will again respond to it and the cycle with inhibition will repeat as well.
We have designed the experiment by two consecutive pulses of TLR stimulation separated by 4-6 hours, which is sufficient time to accumulate the inducible inhibitor. Normal cells should respond to both stimuli, while the cells with our device should respond to the same extent only to the first pulse -- this induces the transcription of the inhibitor, therefore the response to the second stimulus should be decreased. However if the stimuli are separated by a longer timespan, the system should respond normally, as the inhibitor has already degraded and the systemn has reset to the normal state.
Our results show that the system with inducible dnMyD88 indeed responds weaker to the second stimulus. The minimal delay between two stimuli should correspond to the time required for the synthesis of the inhibitor, which is exactly as planned, since it does not completely abolish the cellular response but decreases it after extended stimulation.
Decrease of the protein lifetime by the PEST sequence
Rapid degradation signature motif - "PEST" was considered to tune the lifetime of the inhibitor in order to reset the cells to the normal responsiveness more rapidly. Fusion of the luciferase and PEST sequence under the control of CMV (Device [http://partsregistry.org/Part:BBa_J52039 BBa_J52039]) was used to test the effectiveness of the PEST sequence. We have used the cycloheximide to stop the protein synthesis and analyse the lifetime of the fusion protein with PEST sequence. The steady state of the luciferase activity was 5-10 fold lower in the Rluc-PEST fusin than without of the PEST signature, as evident from the chart below.
Constructs of the dnMyD88 domain and PEST sequence were not effective as inhibitors of signaling because of the interference of the C-terminal extension of the MyD88 inhibitory domain, as described above for the fusion constructs with the reporter luciferase or GFP.
Conclusions
- the same principles of BioBricks can be used in the mammalian cell system as in bacteria and eucaryotes
- we have succesfully implemented a feedback loop that decreases the cellular activation with some delay
- response of this feedback loop is transient and the cell responsiveness is restored after the synthesized inhibitor has degraded
- dnMyD88 inhibitor was not effective as a C-terminal fusion with luciferase or GFP, which may be due to the steric hindrance; it is likely that N-terminal fusion of reporter domains would be functional as signaling inhibitors
- our constructed device mimicks the natural mechanism of tolerance only that it is activated faster, which may be a benefit for organism,
- simplified model of the TLR signaling qualitatively captures most of the features of the natural system
Suggestions
- for mammalian cell systems an additional set of vectors may be constructed based on the backbone, which includes the selection marker for stable transfection or retroviral integration
Home | Background and Signalling Pathway | Project & Model | Methods | Terms & References | Team members |
---|